SCHEMBL19918844

SCHEMBL19918844

COc1cc(C(=O)NC2CCN(C)CC2F)ccc1Nc1ncc(C(F)(F)F)c(Oc2cccc3c2C(=O)CC3)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PTK2 Q05397 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12135079 1.00 PTK2 (1.00) PTK2
SCHEMBL13355038 1.00 PTK2 (1.00) PTK2
SCHEMBL12135083 1.00 PTK2 (1.00) PTK2
SCHEMBL12135082 1.00 PTK2 (1.00) PTK2
SCHEMBL12135084 1.00 PTK2 (1.00) PTK2
SCHEMBL13354981 1.00 PTK2 (1.00) PTK2
SCHEMBL29381547 0.91 PTK2 (1.00) PTK2
SCHEMBL12135103 0.91 PTK2 (1.00) PTK2
SCHEMBL16130899 0.91 PTK2 (0.84) PTK2
SCHEMBL12135027 0.90 PTK2 (1.00) PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2367800-B9 SUBSTITUTED PYRIMIDINES FOR THE TREATMENT OF DISEASES SUCH AS CANCER IPHARMA H K LTD (HK) 2021-10-20 — — EP disclosed
EP-2367800-B1 SUBSTITUTED PYRIMIDINES FOR THE TREATMENT OF DISEASES SUCH AS CANCER BOEHRINGER INGELHEIM INT (DE) 2018-02-28 — — EP disclosed
Send feedback